A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
Start Date
3/20/2023
Completion Date
3/1/2033
Summary
The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency under routine clinical care
Detailed Description
Patients will be treated according to routine clinical practice, and no additional visits, examinations or tests will be required beyond those performed as part of routine clinical practice except for COAs.
Eligibility Criteria
Age Range: No minimum to No maximum
Interventions
No intervention
Conditions
Locations
Ascendis Investigational Site
Phoenix, Arizona 85054
United States
Ascendis Investigational Site
Orange, California 92868
United States
Ascendis Investigational Site
Sacramento, California 95821
United States
Ascendis Investigational Site
San Francisco, California 94143
United States
Ascendis Pharma Investigational Site
Centennial, Colorado 80112
United States
Ascendis Investigational Site
Washington D.C., District of Columbia 20010
United States
Ascendis Investigational Site
Orlando, Florida 32806
United States
Ascendis Investigational Site
Orlando, Florida 32827
United States
Ascendis Investigational Site
Tampa, Florida 33612
United States
Ascendis Investigational Site
Sandy Springs, Georgia 30350
United States
Ascendis Investigational Site
Boise, Idaho 83712
United States
Ascendis Investigational Site
Indianapolis, Indiana 46202
United States
Ascendis Investigational Site
Iowa City, Iowa 52242
United States
Ascendis Investigational Site
Louisville, Kentucky 40202
United States
Ascendis Investigational Site
Minneapolis, Minnesota 55455
United States
Ascendis Investigational Site
Las Vegas, Nevada 89113
United States
Ascendis Investigational Site
Lebanon, New Hampshire 03756
United States
Ascendis Investigational Site
Manchester, New Hampshire 03104
United States
Ascendis Investigational Site
Morristown, New Jersey 07960
United States
Ascendis Investigational Site
New Hyde Park, New York 11042
United States
Ascendis Investigational Site
Cincinnati, Ohio 45229
United States
Ascendis Investigational Site
Portland, Oregon 97239
United States
Ascendis Investigational Site
Columbia, South Carolina 29203
United States
Ascendis Investigational Site
Dallas, Texas 75390
United States
Ascendis Investigational Site
El Paso, Texas 79907
United States
Ascendis Investigational Site
Norfolk, Virginia 23507
United States
Ascendis Investigational Site
Seattle, Washington 98105
United States